Midas Multispecilaity Hopsital Pvt Ltd

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ulcerative colitis

Closed trials

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source